We are continuing our BCS topic, looking at each BCS class in more detail and discussing associated compounding technologies. This week, we will look at Class 2, High Permeability, Low Solubility drugs.
The bioavailability of Class 2 drugs is limited by their rate of solvation. They have a high absorption number but a low dissolution number. Generally, the absorption for Class 2 drugs is slower than Class 1 drugs and occurs over a longer period of time.
List of Class 2 Drugs
A list of Class 2 drugs gathered from several sources includes the following:
Aceclofenac | Ezetimibe | Nicardipine |
Amiodarone | Glibenclamide | Nifedipine |
Atorvastatin | Glipizide | Phenazopyridine |
Azithromycin | Glyburide | Phenytoin |
Bicalutamide | Griseofulvin | Piroxicam |
Carbamazepine | Ibuprofen | Raloxifene |
Carvedilol | Indinavir | Ritonavir |
Chlorpromazine | Indomethacin | Saquinavir |
Cisapride | Itraconazole | Sirolimus |
Ciprofloxacin | Ketoconazole | Spironolactone |
Cyclosporin | Lansoprazole | Tacrolimus |
Danazol | Lovastatin | Talinolol |
Dapsone | Mebendazole | Tamoxifen |
Diclofenac | Mefenamic acid | Terfenadine |
Diflunisal | Naproxen | Troglitazone |
Digoxin | Nelfinavir | |
Erythromycin | Ofloxacin | |
Flurbiprofen | Oxaprozin | |
Compounding Considerations for BCS Class 2 Drugs
This class involves drugs in which the solubility or dissolution rate is limiting, thus potentially significantly affecting absorption and bioavailability.
Particularly for Class 2 drugs, an increase in the solubility and dissolution rate will result in more efficient drug absorption since Class 2 drugs are well absorbed from the GI tract once in solution due to their relatively high lipophilicity.
Methods used in compounding and formulating this class can include:
- Micronization
- Solvent deposition (deposition of poorly soluble drugs on inert material)
- Stabilization of high-energy states (including lyophilized fast-melt systems)
- Use of surfactants
- Forming emulsion or microemulsion systems with the lipophilic drug in the internal phase
- Forming nanoemulsions, nanosuspensions, and nanocrystals
- Forming solid dispersions
- Forming inclusion complexes using complexing agents such as cyclodextrins by kneading, steam granulating, co-precipitating, freeze drying, and spray drying
- Forming polymer strip films
- Soft-gelatin capsule formulation
- Using hot-melt extrusion with a water-soluble carrier
- Use of solvates and hydrates
- Use of salt of weak acids and weak bases
- Buffering the pH of the microenvironment
Next week, we will look in more detail at Class 3.
Loyd V. Allen, Jr., PhD, RPh
Editor-in-Chief
International Journal of Pharmaceutical Compounding
Remington: The Science and Practice of Pharmacy Twenty-second edition
|